Correction: FDA Loosens Controls on Hemostatic Sponges
Correction: The Food and Drug Administration is loosening controls on nonabsorbable expandable hemostatic sponges for temporary internal use by reclassifying them as Class II medical devices (see 14061615).
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.